Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis

NCT02949960 is registered in ClinicalTrials.gov with Dermata Therapeutics as lead sponsor.

NCT NCT02949960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02949960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis
Lead sponsor
Dermata Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2016
Completion date
July 14, 2017
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis